To confirm that LRRK2 with the G2019S substitution increases the toxicity of mutant A53T α-syn when both mutant forms are co-expressed in dopaminergic neurons, rat models mimicking the development of PD have been created (Table 1 and Figure 1A). Here, LRRK2 is linked to Parkinson disease.